The anticancer effects of sulforaphane were found to be mediated by a global DNA hypomethylation, decreased levels of DNMT1 and DNMT3b and changes in the microRNA profiles of the three breast cancer cells lines (Lewinska et al., 2017). The gene discussed is DNMT3B; the disease is breast carcinoma.